Showing 51-60 of 195 results for "".
The Importance of Mentorship
https://practicaldermatology.com/youngmd-connect/wrap-ups/the-importance-of-mentorship/26950/The Importance of MentorshipPsoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of pHS Tips and Lizards
https://practicaldermatology.com/programs/practical-dermatology/hs-tips-and-lizards/35858/The latest news and updates, plus a psoriasis update from Jashin J. Wu, MD, FAAD, at Music City SCALE, and Jennifer L. Hsiao, MD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss treating hidradenitis suppurativa and play a game of "Two Truths and a Lie."Introducing SDDS
https://practicaldermatology.com/topics/practice-management/introducing-sdds/19718/Jashin J. Wu, MD, Founder and Course Director, San Diego Dermatology Symposium, introduces a new meeting with topics in acne, psoriasis, pediatric dermatology, cutaneous oncology, and more. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterConThoughts on Superpotent Topical Corticosteroids in Children
https://practicaldermatology.com/topics/psoriasis/thoughts-on-superpotent-topical-corticosteroids-in-children/18684/"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but super potent topical corticosteroids can be used safely and effectively for pediatric psoriasis patients, he says. Jerry Bagel, MD agrees, in this bonus video from the Clinical ConveDermatology and CTCL: Recommendations
https://practicaldermatology.com/series/dermwire-tv/dermatology-and-ctcl-recommendations/26798/Larisa J. Geskin, MD, Professor of Dermatology at Columbia University Medical Center, discusses "Time to Act: A Global Patient-Focused Consensus for Improving Care in Cutaneous T-Cell Lymphoma (CTCL)," a global consensus statement from Kyowa Kirin that recommends, among other things, that dermatologQuarantine Quorum: Circling the Wagons
https://practicaldermatology.com/topics/practice-management/quarantine-quorum-circling-the-wagons/18180/With Quarantine Quorum, host Neal Bahtia, MD provides a diary of life during the COVID-19 pandemic, talking to members of the dermatology community as they adapt to ongoing changes in their personal and private lives. In this edition, Hilary Baldwin, MD; Adam J. Friedman, MD; Mark Kaufmann, MD; andCOVID-19 Impact: Decisions, decisions: Treating Psoriasis
https://practicaldermatology.com/topics/psoriasis/covid-19-impact-decisions-decisions-treating-psoriasis/19770/Physicians need to carefully weigh the risks and benefits of treating psoriasis patients with biologics or immunosuppressant agents during the COVID-19 pandemic, says Jashin J. Wu, MD. Many factors affect this decision including the severity of the psoriasis as well as any underlying medical conditiIncorporating Cosmetic Dermatology into Your Medical Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/incorporating-cosmetic-dermatology-into-your-medical-practice/18763/Cosmetic Dermatology experts Gary D. Monheit, MD, Nancy J. Samolitis, MD, and Joel L. Cohen, MD share tips for adding aesthetic offerings to an established medical dermatology practice or for young physicians opening a new practice. Sitting down with host Neal Bhatia, MD, they all emphasize the impoDermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-new-data-presented-for-atopic-dermatitis-and-prurigo-nodularis-candidates-at-aad/24127/In this episode of DermWireTV, a phase 3 study finds roflumilast cream is associated with significantly improved atopic dermatitis in children; first-of-its-kind research suggests that eczema treatment lebrikizumab shows efficacy and safety in patients with skin of color; and new data reveals oral J